GB0316546D0 - Process for the manufacture of organic compounds - Google Patents

Process for the manufacture of organic compounds

Info

Publication number
GB0316546D0
GB0316546D0 GBGB0316546.1A GB0316546A GB0316546D0 GB 0316546 D0 GB0316546 D0 GB 0316546D0 GB 0316546 A GB0316546 A GB 0316546A GB 0316546 D0 GB0316546 D0 GB 0316546D0
Authority
GB
United Kingdom
Prior art keywords
manufacture
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0316546.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0316546.1A priority Critical patent/GB0316546D0/en
Publication of GB0316546D0 publication Critical patent/GB0316546D0/en
Priority to PE2009001025A priority patent/PE20091786A1/es
Priority to TW099123665A priority patent/TWI340742B/zh
Priority to PE2004000667A priority patent/PE20050710A1/es
Priority to TW093121028A priority patent/TWI372754B/zh
Priority to MYPI20042814A priority patent/MY176840A/en
Priority to JP2006519892A priority patent/JP5052132B2/ja
Priority to AU2004263265A priority patent/AU2004263265C1/en
Priority to HK06111075.9A priority patent/HK1093509B/en
Priority to SI200431336T priority patent/SI1646636T1/sl
Priority to PL04801815T priority patent/PL1646636T3/pl
Priority to ES04801815T priority patent/ES2336333T3/es
Priority to US10/564,337 priority patent/US7943647B2/en
Priority to DK04801815.4T priority patent/DK1646636T3/da
Priority to KR1020127002953A priority patent/KR20120018826A/ko
Priority to MXPA06000561A priority patent/MXPA06000561A/es
Priority to AT04801815T priority patent/ATE450541T1/de
Priority to ARP040102491A priority patent/AR045995A1/es
Priority to RU2006104322/04A priority patent/RU2006104322A/ru
Priority to EP09167254A priority patent/EP2116548A1/en
Priority to PT04801815T priority patent/PT1646636E/pt
Priority to HR20100088T priority patent/HRP20100088T1/hr
Priority to KR1020137032383A priority patent/KR20130140915A/ko
Priority to PCT/EP2004/007980 priority patent/WO2005014602A1/en
Priority to BRPI0412558-4A priority patent/BRPI0412558A/pt
Priority to CNB2004800264381A priority patent/CN100475823C/zh
Priority to EP04801815A priority patent/EP1646636B1/en
Priority to KR1020067000855A priority patent/KR20060038994A/ko
Priority to KR1020117015621A priority patent/KR101336435B1/ko
Priority to KR1020137029233A priority patent/KR20130127011A/ko
Priority to NZ544644A priority patent/NZ544644A/en
Priority to CA002532175A priority patent/CA2532175A1/en
Priority to DE602004024402T priority patent/DE602004024402D1/de
Priority to IL172946A priority patent/IL172946A/en
Priority to MA28712A priority patent/MA27906A1/fr
Priority to TNP2006000008A priority patent/TNSN06008A1/en
Priority to ZA200600312A priority patent/ZA200600312B/xx
Priority to EC2006006282A priority patent/ECSP066282A/es
Priority to IS8303A priority patent/IS8303A/is
Priority to CO06014919A priority patent/CO5670370A2/es
Priority to NO20060729A priority patent/NO20060729L/no
Priority to CY20101100128T priority patent/CY1109809T1/el
Priority to US13/081,881 priority patent/US20110184187A1/en
Priority to JP2011104199A priority patent/JP2011184451A/ja
Priority to EC2011006282A priority patent/ECSP11006282A/es
Priority to IL216449A priority patent/IL216449A0/en
Priority to US13/603,770 priority patent/US8569528B2/en
Priority to RU2012149012/04A priority patent/RU2012149012A/ru
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C07F5/061—Aluminium compounds with C-aluminium linkage
    • C07F5/066—Aluminium compounds with C-aluminium linkage compounds with Al linked to an element other than Al, C, H or halogen (this includes Al-cyanide linkage)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0316546.1A 2003-07-15 2003-07-15 Process for the manufacture of organic compounds Ceased GB0316546D0 (en)

Priority Applications (48)

Application Number Priority Date Filing Date Title
GBGB0316546.1A GB0316546D0 (en) 2003-07-15 2003-07-15 Process for the manufacture of organic compounds
PE2009001025A PE20091786A1 (es) 2003-07-15 2004-07-14 Proceso para preparar tetrazoles antagonistas del receptor de angiotensina ii
TW099123665A TWI340742B (en) 2003-07-15 2004-07-14 Process for organic compounds
PE2004000667A PE20050710A1 (es) 2003-07-15 2004-07-14 Proceso para la preparacion de derivados de tetrazoles utilizando azidas de organo boro y organo aluminio
TW093121028A TWI372754B (en) 2003-07-15 2004-07-14 Process for organic compounds
MYPI20042814A MY176840A (en) 2003-07-15 2004-07-14 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
JP2006519892A JP5052132B2 (ja) 2003-07-15 2004-07-15 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法
AU2004263265A AU2004263265C1 (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
HK06111075.9A HK1093509B (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
SI200431336T SI1646636T1 (sl) 2003-07-15 2004-07-15 Postopek za pripravo tetrazolnih derivatov iz organoborovih in organoaluminijevih azidov
PL04801815T PL1646636T3 (pl) 2003-07-15 2004-07-15 Sposób przygotowania pochodnych tetrazolu z azydków boroorganicznych i glinoorganicznych
ES04801815T ES2336333T3 (es) 2003-07-15 2004-07-15 Proceso para preparacion de derivados de tetrazol de azidas de organoaluminio y organoboro.
US10/564,337 US7943647B2 (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo aluminium azides
DK04801815.4T DK1646636T3 (da) 2003-07-15 2004-07-15 Fremgangsmåde til fremstilling af tetrazolderivater ud fra organobor- og organoaluminiumazider
KR1020127002953A KR20120018826A (ko) 2003-07-15 2004-07-15 유기 붕소 및 유기 알루미늄 아지드로부터 테트라졸 유도체의 제조 방법
MXPA06000561A MXPA06000561A (es) 2003-07-15 2004-07-15 Proceso para la preparacion de derivados de tetrazol a partir de azidas de organo-boro y de organo-aluminio.
AT04801815T ATE450541T1 (de) 2003-07-15 2004-07-15 Verfahren zur herstellung von tetrazolderivaten aus bororganischen und aluminiumorganischen aziden
ARP040102491A AR045995A1 (es) 2003-07-15 2004-07-15 Proceso para la preparacion de derivados de tetrazoles
RU2006104322/04A RU2006104322A (ru) 2003-07-15 2004-07-15 Способ получения производных тетразола из борорганических и алюминийорганических азидов
EP09167254A EP2116548A1 (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
PT04801815T PT1646636E (pt) 2003-07-15 2004-07-15 Processo para a preparação de derivados tetrazole a partir de azidas de organoboro e organoalumínio
HR20100088T HRP20100088T1 (hr) 2003-07-15 2004-07-15 Postupak priprave derivata tetrazola od organskih bor i organskih aluminij azida
KR1020137032383A KR20130140915A (ko) 2003-07-15 2004-07-15 유기 붕소 및 유기 알루미늄 아지드로부터 테트라졸 유도체의 제조 방법
PCT/EP2004/007980 WO2005014602A1 (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
BRPI0412558-4A BRPI0412558A (pt) 2003-07-15 2004-07-15 processo para a preparação de derivados de tetrazol de azidas de organoboro e organoalumìnio
CNB2004800264381A CN100475823C (zh) 2003-07-15 2004-07-15 从有机硼和有机铝叠氮化物制备四唑衍生物的方法
EP04801815A EP1646636B1 (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
KR1020067000855A KR20060038994A (ko) 2003-07-15 2004-07-15 유기 붕소 및 유기 알루미늄 아지드로부터 테트라졸유도체의 제조 방법
KR1020117015621A KR101336435B1 (ko) 2003-07-15 2004-07-15 유기 붕소 및 유기 알루미늄 아지드로부터 테트라졸 유도체의 제조 방법
KR1020137029233A KR20130127011A (ko) 2003-07-15 2004-07-15 유기 붕소 및 유기 알루미늄 아지드로부터 테트라졸 유도체의 제조 방법
NZ544644A NZ544644A (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
CA002532175A CA2532175A1 (en) 2003-07-15 2004-07-15 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
DE602004024402T DE602004024402D1 (de) 2003-07-15 2004-07-15 Verfahren zur herstellung von tetrazolderivaten au
IL172946A IL172946A (en) 2003-07-15 2006-01-02 Process for the preparation of tetrazole derivatives from organo-boron and organo-aluminium azides
MA28712A MA27906A1 (fr) 2003-07-15 2006-01-06 Processus de preparation de derives de tetrazole issus de bore organo et d'azides d'aluminium organo
TNP2006000008A TNSN06008A1 (en) 2003-07-15 2006-01-09 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
ZA200600312A ZA200600312B (en) 2003-07-15 2006-01-12 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
EC2006006282A ECSP066282A (es) 2003-07-15 2006-01-13 Proceso para la preparación de derivados de tetrazola partir de azidas de órgano-boro y de órgano-aluminio
IS8303A IS8303A (is) 2003-07-15 2006-02-14 Aðferð til að framleiða tetrasólafleiður úr lífrænu bóri og lífrænum álasíðum
CO06014919A CO5670370A2 (es) 2003-07-15 2006-02-15 Proceso para la preparacion de derivados de tetrazol a partir de azidas de organo-boro y de organo-aluminio
NO20060729A NO20060729L (no) 2003-07-15 2006-02-15 Fremgangsmate for fremstilling av tetrazolderivater fra organiske bor- og aluminiumsazider
CY20101100128T CY1109809T1 (el) 2003-07-15 2010-02-10 Διαδικασια για την παρασκευη παραγωγων τετραζολης απο οργανο βοριο και οργανο αργιλιο αζιδια
US13/081,881 US20110184187A1 (en) 2003-07-15 2011-04-07 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
JP2011104199A JP2011184451A (ja) 2003-07-15 2011-05-09 有機ホウ素および有機アルミニウムアジドからのテトラゾール誘導体の調製のための方法
EC2011006282A ECSP11006282A (es) 2003-07-15 2011-07-22 Proceso para la preparación de derivados de tetrazol a partir de azidas de organo-boro y de organo-aluminio
IL216449A IL216449A0 (en) 2003-07-15 2011-11-17 Process for the preparation of tetrazole derivatives
US13/603,770 US8569528B2 (en) 2003-07-15 2012-09-05 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
RU2012149012/04A RU2012149012A (ru) 2003-07-15 2012-11-19 Способ получения производных тетразола из борорганических и алюминийорганических азидов

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0316546.1A GB0316546D0 (en) 2003-07-15 2003-07-15 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
GB0316546D0 true GB0316546D0 (en) 2003-08-20

Family

ID=27763861

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0316546.1A Ceased GB0316546D0 (en) 2003-07-15 2003-07-15 Process for the manufacture of organic compounds

Country Status (34)

Country Link
US (3) US7943647B2 (enExample)
EP (2) EP2116548A1 (enExample)
JP (2) JP5052132B2 (enExample)
KR (5) KR20130140915A (enExample)
CN (1) CN100475823C (enExample)
AR (1) AR045995A1 (enExample)
AT (1) ATE450541T1 (enExample)
AU (1) AU2004263265C1 (enExample)
BR (1) BRPI0412558A (enExample)
CA (1) CA2532175A1 (enExample)
CO (1) CO5670370A2 (enExample)
CY (1) CY1109809T1 (enExample)
DE (1) DE602004024402D1 (enExample)
DK (1) DK1646636T3 (enExample)
EC (2) ECSP066282A (enExample)
ES (1) ES2336333T3 (enExample)
GB (1) GB0316546D0 (enExample)
HR (1) HRP20100088T1 (enExample)
IL (2) IL172946A (enExample)
IS (1) IS8303A (enExample)
MA (1) MA27906A1 (enExample)
MX (1) MXPA06000561A (enExample)
MY (1) MY176840A (enExample)
NO (1) NO20060729L (enExample)
NZ (1) NZ544644A (enExample)
PE (2) PE20050710A1 (enExample)
PL (1) PL1646636T3 (enExample)
PT (1) PT1646636E (enExample)
RU (2) RU2006104322A (enExample)
SI (1) SI1646636T1 (enExample)
TN (1) TNSN06008A1 (enExample)
TW (2) TWI340742B (enExample)
WO (1) WO2005014602A1 (enExample)
ZA (1) ZA200600312B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
JP4537678B2 (ja) * 2003-09-04 2010-09-01 住友化学株式会社 ２’−（１ｈ−テトラゾール−５−イル）ビフェニル−４−カルボアルデヒド結晶およびその製造方法
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan
GB0514206D0 (en) * 2005-07-11 2005-08-17 Novartis Ag Organic compounds
GB0514686D0 (en) * 2005-07-18 2005-08-24 Novartis Ag Organic compounds
WO2007020654A1 (en) * 2005-08-16 2007-02-22 Suven Life Sciences An improved process for the preparation of losartan
WO2007026375A1 (en) * 2005-08-31 2007-03-08 Suven Life Sciences Process for the preparation of losartan
KR100795589B1 (ko) * 2006-05-29 2008-01-21 주식회사 대희화학 2-부틸-4-클로로-1-[[2'-(1ｈ-테트라졸-5-일)바이페닐-4-일]메틸]이미다졸-5-카르복스알데하이드의 제조방법
CN101200455B (zh) * 2007-09-29 2010-08-18 泰兴市江神化工有限公司 沙坦类治疗高血压药物主环5-(4'-甲酰基联苯-2-基)-1h-四氮唑的制备方法
US7932279B2 (en) 2007-10-12 2011-04-26 Arqule, Inc. Substituted tetrazole compounds and uses thereof
EP2316821A1 (en) * 2009-10-27 2011-05-04 Novartis AG Process for the manufacture of organic compounds
US8530506B2 (en) 2009-11-17 2013-09-10 Mitsubishi Tanabe Pharma Corporation Process for production of biphenyl derivative
US10368340B2 (en) * 2010-04-01 2019-07-30 Hon Hai Precision Industry Co., Ltd. Network service exposure method and apparatus utilizing the same
WO2012148148A2 (en) * 2011-04-25 2012-11-01 Lg Life Sciences Ltd. Novel zinc azide complex and a process for preparing tetrazole derivatives using the same
CN102351804B (zh) * 2011-09-30 2013-07-31 浙江新赛科药业有限公司 一种缬沙坦消旋体的回收方法
CN102702117B (zh) * 2012-06-01 2016-04-13 浙江沙星医药化工有限公司 一种制备5-(4’-溴代甲基-2-联苯基)-1-三苯甲基四氮唑的方法
CN103265560B (zh) * 2013-05-17 2016-05-04 中国科学院上海高等研究院 棉酚/棉酮衍生物及其制备方法和抗肿瘤药物中的应用
KR101956281B1 (ko) * 2013-08-13 2019-03-08 삼성전기주식회사 수지 조성물, 이를 이용한 인쇄회로기판 및 그 제조방법
KR102090155B1 (ko) * 2019-11-22 2020-03-17 국방과학연구소 베타인 수용액 내에서 5-치환-1h-테트라졸의 제조방법
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers
CN116375687A (zh) * 2021-12-22 2023-07-04 浙江华海药业股份有限公司 一种高纯度的氯沙坦钾及其制备方法

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977372A (en) * 1958-04-09 1961-03-28 William G Finnegan Process for preparing substituted tetrazoles
US3394142A (en) * 1966-01-19 1968-07-23 Minnesota Mining & Mfg Substituted tetrazoles and process therefor
CH499526A (de) 1968-06-06 1970-11-30 Ciba Geigy Ag Verfahren zur Herstellung von neuen Tetrazolderivaten
SU497775A3 (ru) 1970-01-16 1975-12-30 Циба-Гейги Аг (Фирма) Способ получени производных тетразола
DE2650231A1 (de) * 1976-11-02 1978-05-11 Hoechst Ag Neue imidazolverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4097479A (en) * 1977-03-11 1978-06-27 Miles Laboratories, Inc. Synthesis of 5-substituted tetrazoles
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4288352A (en) 1979-03-26 1981-09-08 Exxon Research & Engineering Co. Electrically conductive polymeric compositions
FI73423C (fi) * 1980-02-29 1987-10-09 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av farmakologiskt verksamma tetrazolderivat.
JPS56158781A (en) 1980-05-10 1981-12-07 Kaken Pharmaceut Co Ltd Tetrazolecoumarin derivative, its preparation and antiallergic agent containing the same as active constitutent
US4338452A (en) * 1980-09-17 1982-07-06 Eli Lilly And Company 1-and 2-(1-Alkyl-1H-tetrazol-5-yl-methyl)-1H-tetrazol-5-thiols and 1-cyanomethyl tetrazole-5-thiol
US4735948A (en) 1983-03-25 1988-04-05 Merrell Dow Pharmaceuticals Inc. (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
JPS6073028A (ja) 1983-09-29 1985-04-25 Japan Electronic Control Syst Co Ltd 電子制御燃料噴射式内燃機関の始動時の噴射量の学習制御装置
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB8708459D0 (en) 1987-04-09 1987-05-13 Avdel Ltd Fastener installation apparatus
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4870186A (en) * 1987-05-22 1989-09-26 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4874867A (en) * 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4831192A (en) * 1987-12-31 1989-05-16 Boc, Inc. Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5210079A (en) * 1988-01-07 1993-05-11 E. I. Du Pont De Nemours And Company Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
US5128069A (en) * 1989-03-22 1992-07-07 Nippon Zoki Pharmaceutical Co., Ltd. Luciferin derivatives
DE122010000024I1 (de) 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
PT97078B (pt) 1990-03-20 1997-07-31 Sanofi Sa Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
JPH04297466A (ja) 1990-06-22 1992-10-21 Nippon Shinyaku Co Ltd テトラゾール誘導体及び医薬
US5284954A (en) 1990-09-10 1994-02-08 Abbott Laboratories Process for the preparation of tetrazoles
AU9137791A (en) 1990-12-14 1992-07-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
US5602127A (en) * 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
US5594003A (en) * 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
IE920540A1 (en) 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
JP2524842Y2 (ja) 1991-02-28 1997-02-05 三菱重工業株式会社 原紙供給装置
US5447949A (en) * 1991-05-15 1995-09-05 Smithkline Beecham Corporation N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity
WO1993004046A1 (en) 1991-08-19 1993-03-04 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives
DK0600950T3 (da) 1991-08-22 1997-04-21 Warner Lambert Co Tetrazolamider som inhibitorer af ACAT
EP0550313A1 (fr) * 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
IL104406A0 (en) 1992-01-17 1993-05-13 Syntex Inc Substituted 1-isoquinolone derivatives,their preparation and pharmaceutical compositions containing them
DE4203872A1 (de) * 1992-02-11 1993-08-12 Thomae Gmbh Dr K Imidazo(1,2-a)pyridine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4206045A1 (de) * 1992-02-27 1993-09-02 Bayer Ag Sulfonylbenzyl substituierte pyridone
US5484955A (en) 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
JP2990566B2 (ja) * 1992-07-06 1999-12-13 武田薬品工業株式会社 トリ高級アルキルスズアジドおよびその用途
JPH06107658A (ja) 1992-09-28 1994-04-19 Kanebo Ltd 新規なピラジン誘導体
US5256658A (en) * 1993-01-15 1993-10-26 Ortho Pharmaceutical Corporation Angiotensin II inhibitors
US5502191A (en) * 1993-07-01 1996-03-26 American Cyanamid Company Method of synthesizing sterically hindered 5-substituted-1H-tetrazoles from nitriles using a lewis acid and an azide
JPH09507075A (ja) * 1993-12-23 1997-07-15 メルク エンド カンパニー インコーポレーテッド ロサルタンの多形とロサルタン▲ｉｉ▼形調製のための方法
JPH09510968A (ja) 1994-03-25 1997-11-04 メリル．フアーマシユウテイカルズ・インコーポレイテツド （１Ｈ−テトラゾル−５−イル）テトラゾロ〔１，５−ａ〕キノリン類およびナフチリジン類の製造方法
CA2186513C (en) 1994-03-28 1999-03-16 James F. Eggler Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
US5541209A (en) 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
JPH08325248A (ja) 1995-05-26 1996-12-10 Chugoku Kayaku Kk テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
JP3671266B2 (ja) 1996-03-21 2005-07-13 東洋化成工業株式会社 ５−置換テトラゾール類の製造方法
JPH10218868A (ja) 1997-02-12 1998-08-18 Toyo Kasei Kogyo Co Ltd ５ーメチルテトラゾールの製造方法
JP4450881B2 (ja) 1998-12-28 2010-04-14 株式会社日本ファインケム ５，５’−ビ−１ｈ−テトラゾール塩の製造方法
JP2000281662A (ja) 1999-03-31 2000-10-10 Masuda Kagaku Kogyo Kk テトラゾール類の製造方法
DE19935219A1 (de) * 1999-07-27 2001-02-01 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
CA2385568A1 (en) * 1999-09-27 2001-04-05 The Dow Chemical Company Supported catalyst comprising expanded anions
US20040072886A1 (en) * 2002-04-15 2004-04-15 Dr. Reddy's Laboratories Limited Novel crystalline forms of (S)-N- (1-Carboxy-2-methyl-prop-1-yl) -N-pentanoyl-N- [2' -(1H-tetrazol-5-yl)- biphenyl-4-yl methyl] amine (Valsartan)
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
US6934312B2 (en) * 2002-09-30 2005-08-23 Agilent Technologies, Inc. System and method for fabricating efficient semiconductor lasers via use of precursors having a direct bond between a group III atom and a nitrogen atom
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
EP1660463B1 (en) * 2003-08-08 2007-12-05 Dipharma Francis S.r.l. A process for the preparation of phenyltetrazole derivatives
BRPI0508164A (pt) 2004-03-17 2007-08-07 Kennecott Utah Copper Corp aparelho e método para monitorar uma célular eletrolìtica

Also Published As

Publication number Publication date
TW200510347A (en) 2005-03-16
MY176840A (en) 2020-08-24
JP5052132B2 (ja) 2012-10-17
PL1646636T3 (pl) 2010-05-31
KR20130140915A (ko) 2013-12-24
CA2532175A1 (en) 2005-02-17
KR20060038994A (ko) 2006-05-04
US20110184187A1 (en) 2011-07-28
ATE450541T1 (de) 2009-12-15
KR20110082096A (ko) 2011-07-15
PE20050710A1 (es) 2005-09-28
EP1646636B1 (en) 2009-12-02
CN100475823C (zh) 2009-04-08
TWI340742B (en) 2011-04-21
ES2336333T3 (es) 2010-04-12
IL172946A (en) 2012-01-31
AU2004263265A1 (en) 2005-02-17
IS8303A (is) 2006-02-14
CO5670370A2 (es) 2006-08-31
RU2012149012A (ru) 2014-05-27
ECSP11006282A (es) 2011-08-31
MA27906A1 (fr) 2006-05-02
JP2011184451A (ja) 2011-09-22
DE602004024402D1 (de) 2010-01-14
AU2004263265C1 (en) 2008-09-25
HRP20100088T1 (hr) 2010-06-30
ECSP066282A (es) 2006-07-28
AR045995A1 (es) 2005-11-23
KR101336435B1 (ko) 2013-12-04
SI1646636T1 (sl) 2010-03-31
NZ544644A (en) 2008-07-31
HK1093509A1 (en) 2007-03-02
AU2004263265B2 (en) 2007-09-06
MXPA06000561A (es) 2006-03-30
KR20120018826A (ko) 2012-03-05
WO2005014602A1 (en) 2005-02-17
US20070043098A1 (en) 2007-02-22
NO20060729L (no) 2006-04-04
PT1646636E (pt) 2010-01-29
IL216449A0 (en) 2011-12-29
US8569528B2 (en) 2013-10-29
BRPI0412558A (pt) 2006-09-19
US20120330026A1 (en) 2012-12-27
KR20130127011A (ko) 2013-11-21
JP2009513555A (ja) 2009-04-02
TNSN06008A1 (en) 2007-10-03
TW201038540A (en) 2010-11-01
CN1852908A (zh) 2006-10-25
RU2006104322A (ru) 2007-09-20
PE20091786A1 (es) 2009-12-14
CY1109809T1 (el) 2014-09-10
EP2116548A1 (en) 2009-11-11
DK1646636T3 (da) 2010-04-06
US7943647B2 (en) 2011-05-17
ZA200600312B (en) 2007-02-28
TWI372754B (en) 2012-09-21
IL172946A0 (en) 2006-06-11
EP1646636A1 (en) 2006-04-19

Similar Documents

Publication Publication Date Title
TWI371438B (en) Process for producing an organic compound
GB0222056D0 (en) Process for the manufacture of organic compounds
ZA200405239B (en) Process for the manufacture of organic compounds
GB0316546D0 (en) Process for the manufacture of organic compounds
PL2266961T3 (pl) Proces syntezy związków organicznych
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
GB0204129D0 (en) Process for the manufacture of organic compounds
PL2322511T3 (pl) Sposób wytwarzania telmisartanu
GB0210234D0 (en) Process for the manufacture of organic compounds
GB0402262D0 (en) Process for the manufacture of organic compounds
IL181355A0 (en) Process for producing n-halogenated organic compounds
TWI347945B (en) Process for the preparation of thiazolopyrimidines
ZA200709621B (en) Process for the synthesis of organic compounds
GB0312966D0 (en) Process for the production of olefins
GB0300095D0 (en) Organic compounds
GB0311836D0 (en) Process for the manufacture of organic compounds
AU2003268738A8 (en) Processes for preparation of organic compounds
PL1698619T3 (pl) Sposób wytwarzania pochodnej 2-halogenobenzamidu
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
IL178960A0 (en) Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
ZA200509495B (en) Process for the preparation of nicotinaldehydes
GB0312968D0 (en) Process for the production of olefins
GB0508433D0 (en) Process for the manufacture of organic compounds
GB0508432D0 (en) Process for the manufacture of organic compounds
HU0300255D0 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)